FIDA BACHA to Drug Approval
This is a "connection" page, showing publications FIDA BACHA has written about Drug Approval.
Connection Strength
0.646
-
FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.
Score: 0.646
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.